Skip to main content
Genome Announcements logoLink to Genome Announcements
. 2014 Oct 16;2(5):e00928-14. doi: 10.1128/genomeA.00928-14

Complete Genome Sequence of Cell Culture-Attenuated Guinea Pig Cytomegalovirus Cloned as an Infectious Bacterial Artificial Chromosome

Dongmei Yang a, Zohaib Alam b, Xiaohong Cui b, Michael Chen a, Carly J Sherrod a, Michael A McVoy b,, Mark R Schleiss c, Dirk P Dittmer a
PMCID: PMC4200145  PMID: 25323707

Abstract

The complete genome sequence of attenuated guinea pig cytomegalovirus cloned as bacterial artificial chromosome N13R10 was determined. Comparison to pathogenic salivary gland-derived virus revealed 13 differences, 1 of which disrupted overlapping open reading frames encoding GP129 and GP130. Attenuation of N13R10 may arise from an inability to express GP129 and/or GP130.

GENOME ANNOUNCEMENT

Guinea pig cytomegalovirus (GPCMV) is a model for congenital CMV infection, an important cause of disability in newborns (1). Salivary gland (SG) extracts of strain 22122 (ATCC VR-682) (2) are highly pathogenic in vivo. As little as 1.7 × 105 PFU results in 60% dam mortality, and a dose as low as 3.5 × 103 can produce up to 80% pup mortality (3). In this dose range, maternal viremia is common and placental and live-born pup infection rates reach 75% (4). Attenuation occurs upon passage in tissue culture. The genome of a tissue culture-attenuated virus has been cloned as bacterial artificial chromosome (BAC) N13R10 (5). Although N13R10-derived virus grows like the wild type in cell culture (5), it is highly attenuated in vivo. A high dose (108 PFU) given to young female guinea pigs caused transient viremia and delayed weight gain, but no mortality (6). A dose of 5 × 105 PFU caused congenital infections in 60% of live-born pups but relatively low (17%) pup mortality (7). Thus, compared to SG virus, adult guinea pigs tolerate a 5,880-fold higher dose of N13R10 without significant illness or mortality, while a 140-fold higher dose of N13R10 during pregnancy produces lower rates of fetal transmission and pup loss.

The sequence of pathogenic SG-22122 (KC503762) was recently obtained by direct sequencing of DNA extracted from SG homogenate (8). To identify potential attenuating mutations, the N13R10 BAC was sequenced on a 454 GS Junior sequencer (Roche). A total of 176,995 reads (average length 405 bp) were de novo assembled using CLC Genomics Workbench version 7.0.4 (CLC bio). Contigs were oriented by BLAST alignment with reference sequence KC503762, and then joined manually. Joined contigs were compared to reference sequence KC503762 and all gaps and differences were resolved by targeted Sanger sequencing (GENEWIZ, Inc., South Plainfield, NJ).

Thirteen differences were observed between N13R10 and KC503762: seven 1-bp differences in the lengths of homopolymeric tracts, two 3-bp differences in the lengths of 3-bp repeats, one 1-bp and one 4-bp deletion, and two 1-bp substitutions. Only two differences altered currently annotated protein coding sequences: (i) a 4-bp deletion/frameshift affecting overlapping genes encoding GP129 and GP130 and (ii) a single amino acid substitution in GP130 that is 3′ of the 4-bp deletion/frameshift.

The function of GP130 is unknown. GP129 is part of a complex analogous to one that mediates entry of human cytomegalovirus into monocytes and epithelial and endothelial cells (912). In GPCMV, mutations disrupting this complex have been hypothesized to contribute to attenuation (9, 1214). The absence of other mutations impacting annotated coding sequences in the N13R10 genome strengthens this hypothesis and further suggests that loss of GP129 and/or GP130 may be the primary and perhaps only mechanism of N13R10’s attenuation. If so, genetic repair of N13R10 to express wild-type GP129 and GP130 may result in a highly pathogenic BAC-cloned GPCMV. The ability to construct viral mutants in a viral strain with enhanced pathogenicity would greatly facilitate vaccine and pathogenesis studies in the GPCMV model of congenital infection.

Nucleotide sequence accession number.

The annotated N13R10 sequence has been deposited in GenBank with the accession number KM384022.

ACKNOWLEDGMENTS

This work was supported by Public Health Service grant 2RO1HD044864 (to M.R.S.) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, grant 5PO1CA019014 (to D.P.D.) from the National Cancer Institute, and grants 1U19AI107810 (to D.P.D.) and 1RO3AI083919 (to M.A.M.) from the National Institute of Allergy and Infectious Diseases.

Footnotes

Citation Yang D, Alam Z, Cui X, Chen M, Sherrod CJ, McVoy MA, Schleiss MR, Dittmer DP. 2014. Complete genome sequence of cell culture-attenuated guinea pig cytomegalovirus cloned as an infectious bacterial artificial chromosome. Genome Announc. 2(5):e00928-14. doi:10.1128/genomeA.00928-14.

REFERENCES

  • 1. Bia FJ, Griffith BP, Fong CK, Hsiung GD. 1983. Cytomegaloviral infections in the guinea pig: experimental models for human disease. Rev. Infect. Dis. 5:177–195. 10.1093/clinids/5.2.177 [DOI] [PubMed] [Google Scholar]
  • 2. Hartley JW, Rowe WP, Huebner RJ. 1957. Serial propagation of the guinea pig salivary gland virus in tissue culture. Proc. Soc. Exp. Biol. Med. 96:281–285. 10.3181/00379727-96-23455 [DOI] [PubMed] [Google Scholar]
  • 3. Bratcher DF, Bourne N, Bravo FJ, Schleiss MR, Slaoui M, Myers MG, Bernstein DI. 1995. Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs. J. Infect. Dis. 172:944–950. 10.1093/infdis/172.4.944 [DOI] [PubMed] [Google Scholar]
  • 4. Schleiss MR. 2006. Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns. Ilar J. 47:65–72. 10.1093/ilar.47.1.65 [DOI] [PubMed] [Google Scholar]
  • 5. Cui X, McGregor A, Schleiss MR, McVoy MA. 2008. Cloning the complete guinea pig cytomegalovirus genome as an infectious bacterial artificial chromosome with excisable origin of replication. J. Virol. Methods 149:231–239. 10.1016/j.jviromet.2008.01.031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Crumpler MM, Choi KY, McVoy MA, Schleiss MR. 2009. A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus infection. Vaccine 27:4209–4218. 10.1016/j.vaccine.2009.04.036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Olejniczak MJ, Choi KY, McVoy MA, Cui X, Schleiss MR. 2011. Intravaginal cytomegalovirus (CMV) challenge elicits maternal viremia and results in congenital transmission in a guinea pig model. Virol. J. 8:89. 10.1186/1743-422X-8-89 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Yang D, Tamburro K, Dittmer D, Cui X, McVoy MA, Hernandez-Alvarado N, Schleiss MR. 2013. Complete genome sequence of pathogenic guinea pig cytomegalovirus from salivary gland homogenates of infected animals. Genome Announc. 1(2):e0005413. 10.1128/genomeA.00054-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Auerbach M, Yan D, Fouts A, Xu M, Estevez A, Austin CD, Bazan F, Feierbach B. 2013. Characterization of the guinea pig CMV gH/gL/GP129/GP131/GP133 complex in infection and spread. Virology 441:75–84. 10.1016/j.virol.2013.03.008 [DOI] [PubMed] [Google Scholar]
  • 10. Yamada S, Nozawa N, Katano H, Fukui Y, Tsuda M, Tsutsui Y, Kurane I, Inoue N. 2009. Characterization of the guinea pig cytomegalovirus genome locus that encodes homologs of human cytomegalovirus major immediate-early genes, UL128, and UL130. Virology 391:99–106. 10.1016/j.virol.2009.05.034 [DOI] [PubMed] [Google Scholar]
  • 11. Gnanandarajah JS, Gillis PA, Hernandez-Alvarado N, Higgins L, Markowski TW, Sung H, Lumley S, Schleiss MR. 2014. Identification by mass spectrometry and immune response analysis of guinea pig cytomegalovirus (GPCMV) pentameric complex proteins GP129, 131 and 133. Viruses 6:727–751. 10.3390/v6020727 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Yamada S, Fukuchi S, Hashimoto K, Fukui Y, Tsuda M, Kataoka M, Katano H, Inoue N. 2014. Guinea pig cytomegalovirus GP129/131/133, homologues of human cytomegalovirus UL128/130/131A, are necessary for infection of monocytes and macrophages. J. Gen. Virol. 95:1376–1382. 10.1099/vir.0.064527-0 [DOI] [PubMed] [Google Scholar]
  • 13. Nozawa N, Yamamoto Y, Fukui Y, Katano H, Tsutsui Y, Sato Y, Yamada S, Inami Y, Nakamura K, Yokoi M, Kurane I, Inoue N. 2008. Identification of a 1.6-kb genome locus of guinea pig cytomegalovirus required for efficient viral growth in animals but not in cell culture. Virology 379:45–54. http://www.sciencedirect.com/science/article/pii/S004268220800411X [DOI] [PubMed] [Google Scholar]
  • 14. Schleiss MR, McVoy MA. 2010. Guinea pig cytomegalovirus (GPCMV): a model for the study of the prevention and treatment of maternal-fetal transmission. Future Virol. 5:207–217. 10.2217/fvl.10.8 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Genome Announcements are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES